HCA Healthcare, Inc.
New York Stock ExchangeRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- HCA Healthcare, Inc. (NYSE: HCA) operates as one of the largest for-profit health systems in the United States, owning and managing approximately 190 hospitals and 2,400 ambulatory sites of care including surgery centers, freestanding emergency rooms, urgent care centers, diagnostic and imaging centers, walk-in clinics, and physician clinics; it provides a comprehensive range of services encompassing acute inpatient care, outpatient services, emergency services, surgical services, diagnostic imaging, rehabilitation services, cardiology, oncology, orthopedics, neurology, and advanced maternal and fetal care across 20 states and the United Kingdom. Founded in 1968 by Dr. Thomas F. Frist Sr., Dr. Thomas F. Frist Jr., and Jack C. Massey, the company is headquartered in Nashville, Tennessee, and serves approximately 44 million patient encounters annually through its integrated network focused on high-quality, convenient care for diverse patient populations including those requiring high-acuity treatments and community-based services. HCA Healthcare maintains significant market presence in key regions such as Florida with 47 hospitals and 31 surgery centers, Texas with 45 hospitals and over 600 affiliated sites, and Tennessee with 13 hospitals, while supporting medical education as the largest sponsor of graduate medical education programs in the U.S. with 56 teaching hospitals. Recent strategic developments include the rollout of the cloud-based MEDITECH Expanse electronic health record platform across all acute care facilities to enhance data insights, care coordination, and innovation; the launch of CareIntel for Perinatal in collaboration with GE HealthCare to advance maternal and fetal healthcare through AI-driven clinical insights; implementation of virtual nursing programs and digital transformation initiatives to streamline operations and improve patient outcomes; authorization of a $10 billion share repurchase program in January 2025 with ongoing executions totaling billions in recent years; and planned expansions such as a new 68-bed hospital in Clarksville, Tennessee, alongside facility enhancements in Florida and California. In April 2025, HCA divested Regional Medical Center in East San Jose, California, to Santa Clara Valley Healthcare for $150 million, reflecting selective portfolio optimization amid broader growth efforts.
Can HCA's Gene Therapy Milestone Drive Long-Term Growth?
HCA Healthcare Announces New England Journal of Medicine Study Highlighting Advances in CRISPR-based Therapy for Children
HCA Healthcare (HCA) is a Top-Ranked Growth Stock: Should You Buy?
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term
Why HCA Healthcare (HCA) is a Top Value Stock for the Long-Term
Healthcare Added 35,200 Jobs—3 Stocks Positioned to Benefit
Is HCA Undervalued? DCF Says Worth $765
Mission Bio and Human Cell Atlas Collaborate to Expand Access to Single-Cell Multiomics Ahead of HCA 2026 Meeting
Vizgen® to Advance Cell Atlases with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting
Top 50 High-Quality Dividend Growth Stocks For June 2026
3 Beaten-Down Stocks to Buy and Hold Forever
HCA Healthcare to Acquire CHCP to Strengthen Workforce Development
HCA Healthcare Announces Agreement to Acquire The College of Health Care Professions
Is HCA Undervalued? DCF Says Worth $765
HCA Healthcare, Inc. (HCA) Presents at RBC Capital Markets Global Healthcare Conference 2026 Transcript
HCA Healthcare Colleagues Volunteer More Than 41,800 Hours During Annual Days of Service Initiative
HCA DCF Analysis: Intrinsic Value $765 vs Price $423
HCA DCF Analysis: Intrinsic Value $765 vs Price $429
HCA Healthcare, Inc. to Present at May Conference
Why Investors Need to Take Advantage of These 2 Medical Stocks Now